Little RD, Swaine A, Reynolds R, Gibson DJ, et al. Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study. Inflamm Bowel Dis 2023 Nov 10:izad248. doi: 10.1093.
PMID: 37951220